Concepedia

Michael Kahle

MK

17

Publications

666

Citations

14

H-Index

2010

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Texas A&M Health Science Center

University of Kentucky

Texas A&M University

Loyola University Chicago

Michael Kahle is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyNeurologyPathologyBrain InjuryTumor BiologyCerebral Blood FlowHealthStrokeAngiogenesis

Publications per year

2010–2023

17

Publications

17

Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents

Boyeon Lee, Douglas Clarke, Abraham Al Ahmad et al. · Journal of Clinical Investigation · 2011 · 139 citations

Pathology, Cerebrovascular Disease, Cell Death +23

Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?

Jill Roberts, Michael Kahle, Gregory Bix · Frontiers in Pharmacology · 2012 · 64 citations · Full text

Successfully Climbing the “STAIRs”: Surmounting Failed Translation of Experimental Ischemic Stroke Treatments

Michael Kahle, Gregory Bix · Stroke Research and Treatment · 2012 · 62 citations · Full text

Cerebrovascular Disease, “ Stairs ”, Stroke Therapies +21

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC

Jeffrey H. Becker, Yandi Gao, Margaret Soucheray et al. · Cancer Research · 2019 · 61 citations · Full text

Precision Oncology: Evolving Clinical Trials across Tumor Types

I-Wen Song, Henry Hiep Vo, Ying‐Shiuan Chen et al. · Cancers · 2023 · 57 citations · Full text

Rows per page

1–5 of 17